5513-40-6

Basic information

• Product Name: Z-TYR-OBZL
• Synonyms: N-ALPHA-CARBOBENZOXY-L-TYROSINE-BENZYL ESTER;Z-TYR-OBZL;Z-TYROSINE-OBZL;Z-L-TYROSINE-BENZYL ESTER;(S)-Benzyl 2-(benzyloxycarbonylamino)-3-(4-hydroxyphenyl)propanoate;Cbz-L-Tyrosine benzyl ester;L-Tyrosine, N-[(phenylMethoxy)carbonyl]-, phenylMethyl ester;N-Cbz-L-Tyrosine benzyl ester
• CAS NO: 5513-40-6
• Molecular Formula: C₂₄H₂₃NO₅
• Molecular Weight: 405.44
• EINECS: 200-582-5
• Mol File: 5513-40-6.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 610.8±55.0 °C(Predicted)
• Appearance: /
• Density: 1.250±0.06 g/cm3(Predicted)
• Storage Temp.: Room temperature.
• PKA: 9.74±0.15(Predicted)
• CAS DataBase Reference: Z-TYR-OBZL(CAS DataBase Reference)
• NIST Chemistry Reference: Z-TYR-OBZL(5513-40-6)
• EPA Substance Registry System: Z-TYR-OBZL(5513-40-6)

Safety Data

• Hazardous Substances Data: 5513-40-6(Hazardous Substances Data)

Usage

General Description

"Z-TYR-OBZL" is a synthetic chemical compound that falls under the category of designer drugs. It has properties similar to those of psychoactive substances like opioids and stimulants. Z-TYR-OBZL is known to cause various effects on the central nervous system, including increased energy, heightened alertness, euphoria, and altered sensory perception. It is also considered potentially addictive and has been associated with negative health effects such as increased heart rate, high blood pressure, and potential neurotoxicity. Due to its psychoactive properties and potential for harm, Z-TYR-OBZL is often categorized as a controlled substance with legal and regulatory restrictions on its production, distribution, and use.

Upstream product

• 42406-77-9 L-tyrosine benzyl ester 
• 501-53-1 benzyl chloroformate 
• 213757-66-5 (S)-2-Benzyloxycarbonylamino-3-(4-hydroxy-3-iodo-phenyl)-propionic acid benzyl ester 
• 600737-80-2 (S)-2-Benzyloxycarbonylamino-3-[4-hydroxy-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-propionic acid benzyl ester 
• 1164-16-5 Z-L-Tyr-OH 
• 100-51-6 benzyl alcohol 
• 100-39-0 benzyl bromide 
• 114542-77-7 C₂₆H₂₅F₃NO₇P 
• 60-18-4 L-tyrosine 
• 53587-11-4 L-tyrosine benzyl ester p-toluenesulfonate 

Downstream Products

• 13852-48-7 O--L-tyrosin 
• 100083-90-7 N-Benzyloxycarbonyl-O-(2,3,4,6-tetra-O-pivaloyl-β-D-glucopyranosyl)-L-tyrosin-benzylester 
• 146900-32-5 (S)-2-Benzyloxycarbonylamino-3-[4-(benzyloxy-diisopropylamino-phosphanyloxy)-phenyl]-propionic acid benzyl ester 
• 107932-33-2 (S)-2-Benzyloxycarbonylamino-3-[4-((2S,3R,4S,5R,6R)-3,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yloxy)-phenyl]-propionic acid benzyl ester 
• 107932-32-1 (S)-2-Benzyloxycarbonylamino-3-[4-((2R,3R,4S,5R,6R)-3,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yloxy)-phenyl]-propionic acid benzyl ester 
• 146900-34-7 (S)-3-{Benzyloxy-[4-((S)-2-benzyloxycarbonyl-2-benzyloxycarbonylamino-ethyl)-phenoxy]-phosphoryloxy}-2-benzyloxycarbonylamino-propionic acid benzyl ester 
• 183070-41-9 L-N^α-Cbz-4-(O-trifluoromethanesulfonate)tyrosine benzyl ester 
• 172611-20-0 C₃₀H₃₈N₃O₆P 
• 177941-85-4 C₃₀H₃₈N₃O₆P 
• 213698-01-2 C₃₂H₄₂N₃O₆P 
• 213757-54-1 (S)-2-Benzyloxycarbonylamino-3-(4-tert-butoxycarbonylmethoxy-phenyl)-propionic acid benzyl ester 
• 262603-98-5 Cbz-Tyr(Nf)-OBzl 
• 213757-66-5 (S)-2-Benzyloxycarbonylamino-3-(4-hydroxy-3-iodo-phenyl)-propionic acid benzyl ester 
• 600737-77-7 (S)-2-Benzyloxycarbonylamino-3-(4-methoxy-phenyl)-propionic acid benzyl ester 

Relevant articles and documents

Discovery of Modified Amidate (ProTide) Prodrugs of Tenofovir with Enhanced Antiviral Properties

This study describes the discovery of novel prodrugs bearing tyrosine derivatives instead of the phenol moiety present in FDA-approved tenofovir alafenamide fumarate (TAF). The synthesis was optimized to afford diastereomeric mixtures of novel prodrugs in

Synthesis method of O-[2]-[[tert-Butoxycarbonyl]amino]ethyl]-N-[fluorene methoxycarbonyl]-L-tyrosine

The invention relates to a synthesis method of O-[2]-[[tert-Butoxycarbonyl]amino]ethyl]-N-[fluorene methoxycarbonyl]-L-tyrosine. The present invention mainly solves the technical problem of high scale-up production cost existing in the present synthesis m

Phosphylated tyrosine in albumin as a biomarker of exposure to organophosphorus nerve agents

The organophosphorus nerve agents sarin, soman, cyclosarin and tabun phosphylate a tyrosine residue on albumin in human blood. These adducts may offer relatively long-lived biological markers of nerve agent exposure that do not 'age' rapidly, and which ar